Progress Software reports Q3 FY26 results tonight, and the setup is genuinely split: short interest is running at more than 10% of the free float, yet options traders are the most bullish they have been in months.
The options signal is the sharpest data point this week. The put/call ratio has collapsed to 0.29, nearly 1.4 standard deviations below its 20-day average of 0.64. That places call-side demand at close to its highest relative level of the past year, the 52-week low on the PCR is 0.19. Notably, the ratio dropped sharply after September 21, falling from around 0.82 to the current level over roughly a week, a hard shift in positioning that coincides with the stock sliding 12% over the past month to $39.44. Options traders appear to be positioning for a bounce, not bracing for more downside.
Short interest tells a more cautious structural story. Bears hold roughly 10.7% of the free float short, a level ORTEX flags as high. The absolute short share count has been drifting lower through September, down from around 4.79 million shares in mid-September to 4.57 million now, a roughly 0.3% week-on-week decline. But the position remains large. Borrow conditions give shorts no particular urgency to cover: cost to borrow is just 0.40%, down 3.8% on the week and 13% over the past month, and availability is around 306% of short interest, meaning the lending pool has roughly three times as many shares available as are currently borrowed. There is no squeeze dynamic in play.
The Street broadly likes the stock but is divided on near-term momentum. The consensus is a buy across four covering analysts, with a mean price target of $56.20 against the current $39.44 price, implying about 42% upside. DA Davidson raised its target to $55 in August and maintained its buy rating, though Guggenheim's maintained $83 target stands out as a notable outlier versus the pack. The bear case centres on tonight's print: Q3 guidance came in around $3 million below consensus when it was issued, with management citing deal pull-forward from Q3 into Q2 as the culprit. ARR growth of 2% year-on-year in constant currency and net revenue retention at exactly 100% point to a stable but not accelerating business. The bull case rests on 40% adjusted operating margins, strong free cash flow, and a data platform that bulls argue is well positioned for enterprise AI governance and data sovereignty demand. EV/EBITDA has compressed by roughly one turn over the past 30 days to 6.5x, reflecting the recent price weakness.
The ORTEX short score has been climbing through the week, reaching 65.9 on September 29, up from 63.6 a week earlier. Its rank in the 8th percentile on short score within the systems software universe is a flag worth noting: most peers carry lighter short positioning. Among close peers, NOW fell 5.2% on the week and VERX dropped 5.4%, while FRSH gained 1.3%. PRGS, down about 2.9% on the week, sits roughly in the middle of the cohort's recent range.
Insider activity over the past 90 days runs net negative at roughly 33,800 shares sold and $1.26 million in net value, though the open-market sales from CFO Anthony Folger and EVP Loren Jarrett were both conducted under pre-arranged 10b5-1 plans, which reduces their signalling weight considerably. The July director share grants are compensation mechanics rather than conviction trades.
Tonight's Q3 print is the clearest near-term test: the question is whether management's pull-forward explanation holds up in the numbers, or whether the guidance miss pointed to something more persistent in the demand picture.
See the live data behind this article on ORTEX.
Open PRGS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
